Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell’Emostasi e della Trombosi (SISET)

Direct oral anticoagulants (DOAC) are mostly prescribed to prevent cardioembolic stroke in patients with non-valvular atrial fibrillation (AF). An increasing number of guidelines recommend DOAC in AF patients with preserved renal function for the prevention of thromboembolism and an increased use of...

Descripción completa

Detalles Bibliográficos

Autores principales:	Grandone, Elvira, Aucella, Filippo, Barcellona, Doris, Brunori, Giuliano, Forneris, Giacomo, Gresele, Paolo, Marietta, Marco, Poli, Daniela, Testa, Sophie, Tripodi, Armando, Genovesi, Simonetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Position papers and Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881955/ https://www.ncbi.nlm.nih.gov/pubmed/32757171 http://dx.doi.org/10.1007/s40620-020-00768-3